POT1 tumour predisposition syndrome (POT1-TPD) is inherited in an autosomal dominant manner and associated with an increased lifetime risk of cutaneous melanoma (CM), chronic lymphocytic leukaemia (CLL), angiosarcoma (mostly cardiac angiosarcomas) and gliomas [1–3, 7–13]. The gene discussed is POT1; the disease is cutaneous mastocytosis.